Studies on other types of inhibitors, such as ATP-competitive mTOR inhibitors and mTOR/PI3K dual inhibitors, have also shown tumor growth inhibition effects against CRC cell lines and xenograft models [68, 69]. The gene discussed is MTOR; the disease is colorectal carcinoma.